Characteristics and Outcomes of Patients with Hospital-Acquired Pneumonia (Hap)

S. Han,J. Xie,H. Song,C. Zhang,E. Q. Wu

DOI: https://doi.org/10.1016/j.jval.2016.08.749

IF: 5.156

2016-01-01

Value in Health

Abstract:This study aimed to describe characteristics and outcomes of patients with hospital-acquired pneumonia (HAP) in China. A large electronic medical record database (2009-2015) from three tertiary hospitals in three metropolitan cities in China was used. Adult patients (≥18 years) with ≥1 hospitalization associated with HAP were selected. HAP-related hospitalizations were identified if the first pneumonia diagnosis was after 3 days of admission or if the first pneumonia diagnosis occurred within 3 days of admission and the gap between the discharge date from the prior hospitalization and the admission date was < 10 days. The first HAP-related hospitalization for each patient was selected into the current sample. Patient characteristics, culture test results, length of stay (LOS), and costs (2015 RMB) were described. Kaplan-Meier analysis was used to estimate rate of recurrent hospitalizations after discharge. 413 patients with HAP-related hospitalizations were selected with a mean age of 55.0±18.3 years, 31.2% over 65 years, 72.2% men, 71.7% insured and 38.0% admitted with critical/emergent condition at the initial hospitalization with HAP. The most common comorbidities were stroke (12.8%), ischemic heart disease (6.5%), chronic obstructive pulmonary disease (6.1%) and heart failure (5.6%). About 66.6% of patients received culture tests during hospitalization. Among the tested patients, the most commonly identified bacteria were klebsiella pneumoniae (17.5%), pseudomonas aeruginosa (10.9%), staphylococcus aureus (6.5%) and staphylococcus epidermidis (4.0%). Median LOS was 21 (interquartile range: 11 to 43) days. Median total, pharmacy and non-pharmacy costs were ¥56,383.7, ¥26,286.2, and ¥27,849.0, respectively. Rate of all-cause and pneumonia-related recurrent hospitalizations at 30 days were 12.2% and 1.8%, respectively. The corresponding numbers at one year were 27.2% and 4.5%, respectively. The majority of patients with HAP in our sample were <65 years and male, with different comorbidities. HAP was associated with a high economic burden with a relatively high all-cause recurrent hospitalization rate.